PT3286198T - Compostos para tratar condições pruriginosas - Google Patents

Compostos para tratar condições pruriginosas

Info

Publication number
PT3286198T
PT3286198T PT167840198T PT16784019T PT3286198T PT 3286198 T PT3286198 T PT 3286198T PT 167840198 T PT167840198 T PT 167840198T PT 16784019 T PT16784019 T PT 16784019T PT 3286198 T PT3286198 T PT 3286198T
Authority
PT
Portugal
Prior art keywords
compounds
pruritic conditions
treating pruritic
treating
conditions
Prior art date
Application number
PT167840198T
Other languages
English (en)
Original Assignee
Trevi Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trevi Therapeutics Inc filed Critical Trevi Therapeutics Inc
Publication of PT3286198T publication Critical patent/PT3286198T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PT167840198T 2015-04-23 2016-04-22 Compostos para tratar condições pruriginosas PT3286198T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562151618P 2015-04-23 2015-04-23

Publications (1)

Publication Number Publication Date
PT3286198T true PT3286198T (pt) 2021-04-26

Family

ID=57144302

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167840198T PT3286198T (pt) 2015-04-23 2016-04-22 Compostos para tratar condições pruriginosas

Country Status (15)

Country Link
US (1) US9624233B2 (pt)
EP (1) EP3286198B1 (pt)
JP (1) JP6744327B2 (pt)
AU (1) AU2016252892B2 (pt)
CA (1) CA2981625C (pt)
CY (1) CY1124163T1 (pt)
DK (1) DK3286198T3 (pt)
ES (1) ES2867799T3 (pt)
HR (1) HRP20210606T1 (pt)
HU (1) HUE054399T2 (pt)
LT (1) LT3286198T (pt)
PL (1) PL3286198T3 (pt)
PT (1) PT3286198T (pt)
SI (1) SI3286198T1 (pt)
WO (1) WO2016172613A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111116597A (zh) * 2018-10-31 2020-05-08 扬子江药业集团江苏紫龙药业有限公司 一种纳布啡游离碱的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477456A (en) * 1981-07-02 1984-10-16 E. I. Du Pont De Nemours And Company Octahydro-4A,7-ethano- and -etheno-benzofuro[3,2-e]isoquinoline derivatives having analgesic, narcotic antagonist and anorexigenic properties
US7195882B2 (en) * 2003-06-03 2007-03-27 Roche Diagnostics Operations, Inc. Monoclonal antibodies specific for buprenorphine and metabolites thereof
TWI553009B (zh) * 2007-03-29 2016-10-11 普吉尼製藥公司 末梢性類鴉片受體拮抗劑及其用途

Also Published As

Publication number Publication date
CA2981625C (en) 2023-05-23
CA2981625A1 (en) 2016-10-27
HUE054399T2 (hu) 2021-09-28
EP3286198A1 (en) 2018-02-28
SI3286198T1 (sl) 2021-08-31
EP3286198A4 (en) 2018-09-26
US20160311832A1 (en) 2016-10-27
EP3286198B1 (en) 2021-02-24
HRP20210606T1 (hr) 2021-05-28
AU2016252892A1 (en) 2017-10-26
WO2016172613A1 (en) 2016-10-27
DK3286198T3 (da) 2021-05-03
JP6744327B2 (ja) 2020-08-19
LT3286198T (lt) 2021-07-12
AU2016252892B2 (en) 2019-05-02
US9624233B2 (en) 2017-04-18
PL3286198T3 (pl) 2021-09-06
ES2867799T3 (es) 2021-10-20
JP2018513174A (ja) 2018-05-24
CY1124163T1 (el) 2022-05-27

Similar Documents

Publication Publication Date Title
HK1245804A1 (zh) 用於治療pvns的抗csf1r抗體
HK1244217A1 (zh) 用於治療蛋白質病的方法
HK1255871A1 (zh) 用於治療骨髓瘤的賽度替尼
HK1251965A1 (zh) 用於治療癲癇的方法
IL249475A0 (en) Methods for treating itching
HK1250649A1 (zh) 用於治療白血病的抗-s100a8
HK1249901B (zh) 用於抑制ror-gamma-t的化合物
HK1248133A1 (zh) 治療神經母細胞瘤的方法
HK1255481A1 (zh) 用於治療hcv的方法
GB201508747D0 (en) Compounds
PT3250218T (pt) Péptido natkide para o tratamento da obesidade
EP3130586A4 (en) Process for treating homoserine-based compound
HK1259615A1 (zh) 谷氨酸-高z元素化合物治療癌症
SI3286198T1 (sl) Spojine za zdravljenje pruritičnih stanj
HK1254378A1 (zh) [(2-乙氧基-5-反式-1-丙烯-1-基)-苯氧基]封端化合物
IL249616A0 (en) Methods for treating inflammation
EP3246432A4 (en) Method for treating parts
PL3131890T3 (pl) Związki do leczenia zakażeń wirusowych
GB201508857D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201709559D0 (en) Compounds for treating lupus
GB201508453D0 (en) Compounds
GB201508454D0 (en) Compounds
GB201505674D0 (en) Compounds